Outer membrane vesicles induce immune responses to virulence proteins and protect against colonization by enterotoxigenic Escherichia coli

Clinical and Vaccine Immunology

Volumn 18, Issue 11, 2011, Pages 1803-1808

  Roy, Koushik ^a   Hamilton, David J ^a   Munson, George P ^b   Fleckenstein, James M ^a,c  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADHESIN; BACTERIAL TOXIN; CEXE PROTEIN; ESCHERICHIA COLI VACCINE; ETPA ADHESIN; HEAT LABILE TOXIN; HEAT STABLE TOXIN; UNCLASSIFIED DRUG; VIRULENCE FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL OUTER MEMBRANE; CELL FUNCTION; CELL STRUCTURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENTEROTOXIGENIC ESCHERICHIA COLI; ESCHERICHIA COLI INFECTION; IMMUNITY; IMMUNIZATION; IMMUNOGENICITY; IMMUNOSTIMULATION; MEMBRANE VESICLE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; SMALL INTESTINE;

ANIMALS; ANTIBODIES, BACTERIAL; BACTERIAL TOXINS; ENTEROTOXIGENIC ESCHERICHIA COLI; ENTEROTOXINS; ESCHERICHIA COLI INFECTIONS; ESCHERICHIA COLI PROTEINS; ESCHERICHIA COLI VACCINES; EXOSOMES; INTESTINE, SMALL; MICE; VIRULENCE FACTORS;

EID: 80455143346     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.05217-11     Document Type: Article

References (34)

1. Allen, K. P., M. M. Randolph, and J. M. Fleckenstein. 2006. Importance of heat-labile enterotoxin in colonization of the adult mouse small intestine by human enterotoxigenic Escherichia coli strains. Infect. Immun. 74:869-875. (Pubitemid 43185519)
2. Azizi, A., A. Kumar, F. Diaz-Mitoma, and J. Mestecky. 2010. Enhancing oral vaccine potency by targeting intestinal M cells. PLoS Pathog. 6:e1001147.
3. Berberov, E. M., et al. 2004. Relative importance of heat-labile enterotoxin in the causation of severe diarrheal disease in the gnotobiotic piglet model by a strain of enterotoxigenic Escherichia coli that produces multiple enterotoxins. Infect. Immun. 72:3914-3924. (Pubitemid 38821905)
4. Bishop, A. L., S. Schild, B. Patimalla, B. Klein, and A. Camilli. 2010. Mucosal immunization with Vibrio cholerae outer membrane vesicles provides maternal protection mediated by antilipopolysaccharide antibodies that inhibit bacterial motility. Infect. Immun. 78:4402-4420.
5. Boedeker, E. C. 2005. Vaccines for enterotoxigenic Escherichia coli: current status. Curr. Opin. Gastroenterol. 21:15-19. (Pubitemid 40189218)
6. Chen, D. J., et al. 2010. Delivery of foreign antigens by engineered outer membrane vesicle vaccines. Proc. Natl. Acad. Sci. U. S. A. 107:3099-3104.
7. Couch, R. B. 2004. Nasal vaccination, Escherichia coli enterotoxin, and Bell's palsy. N. Engl. J. Med. 350:860-861. (Pubitemid 38252532)
8. Dorsey, F. C., J. F. Fischer, and J. M. Fleckenstein. 2006. Directed delivery of heat-labile enterotoxin by enterotoxigenic Escherichia coli. Cell. Microbiol. 8:1516-1527. (Pubitemid 44194582)
9. Evans, D. J., Jr., and D. G. Evans. 1973. Three characteristics associated with enterotoxigenic Escherichia coli isolated from man. Infect. Immun. 8:322-328.
10. Findlow, J., et al. 2010. Multicenter, open-label, randomized phase II controlled trial of an investigational recombinant meningococcal serogroup B vaccine with and without outer membrane vesicles, administered in infancy. Clin. Infect. Dis. 51:1127-1137.
11. Fleckenstein, J. M., and K. Roy. 2009. Purification of recombinant high molecular weight two-partner secretion proteins from Escherichia coli. Nat. Protoc. 4:1083-1092.
12. Haurat, M. F., et al. 2011. Selective sorting of cargo proteins into bacterial membrane vesicles. J. Biol. Chem. 286:1269-1276.
13. Holmgren, J., and C. Czerkinsky. 2005. Mucosal immunity and vaccines. Nat. Med. 11:S45-S53. (Pubitemid 40562303)
14. Holst, J., et al. 2009. Properties and clinical performance of vaccines containing outer membrane vesicles from Neisseria meningitidis. Vaccine 27(Suppl. 2):B3-B12.
15. Horstman, A. L., and M. J. Kuehn. 2002. Bacterial surface association of heat-labile enterotoxin through lipopolysaccharide after secretion via the general secretory pathway. J. Biol. Chem. 277:32538-32545. (Pubitemid 34987554)
16. Horstman, A. L., and M. J. Kuehn. 2000. Enterotoxigenic Escherichia coli secretes active heat-labile enterotoxin via outer membrane vesicles. J. Biol. Chem. 275:12489-12496. (Pubitemid 30241392)
17. Johnson, A. M., R. S. Kaushik, D. H. Francis, J. M. Fleckenstein, and P. R. Hardwidge. 2009. Heat-labile enterotoxin promotes Escherichia coli adherence to intestinal epithelial cells. J. Bacteriol. 191:178-186.
18. Kesty, N. C., K. M. Mason, M. Reedy, S. E. Miller, and M. J. Kuehn. 2004. Enterotoxigenic Escherichia coli vesicles target toxin delivery into mammalian cells. EMBO J. 23:4538-4549. (Pubitemid 39657854)
19. Kuehn, M. J., and N. C. Kesty. 2005. Bacterial outer membrane vesicles and the host-pathogen interaction. Genes Dev. 19:2645-2655. (Pubitemid 41627932)
20. Kulp, A., and M. J. Kuehn. 2010. Biological functions and biogenesis of secreted bacterial outer membrane vesicles. Annu. Rev. Microbiol. 64:163-184.
21. P13F) of human enterotoxigenic Escherichia coli elicited neutralizing antitoxin antibodies. Infect. Immun. 79:4002-4009.
22. Muralinath, M., M. J. Kuehn, K. L. Roland, and R. Curtiss III. 2011. Immunization with Salmonella enterica serovar Typhimurium-derived outer membrane vesicles delivering the pneumococcal protein PspA confers protection against challenge with Streptococcus pneumoniae. Infect. Immun. 79:887-894.
23. Mutsch, M., et al. 2004. Use of the inactivated intranasal influenza vaccine and the risk of Bell's palsy in Switzerland. N. Engl. J. Med. 350:896-903.
24. National Research Council. 1996. Guide for the care and use of laboratory animals. National Academy Press, Washington, DC.
25. Pilonieta, M. C., M. D. Bodero, and G. P. Munson. 2007. CfaD-dependent expression of a novel extracytoplasmic protein from enterotoxigenic Escherichia coli. J. Bacteriol. 189:5060-5067. (Pubitemid 47076051)
26. Rasko, D. A., et al. 2008. The pangenome structure of Escherichia coli: comparative genomic analysis of E. coli commensal and pathogenic isolates. J. Bacteriol. 190:6881-6893.
27. Rivera, J., et al. 2010. Bacillus anthracis produces membrane-derived vesicles containing biologically active toxins. Proc. Natl. Acad. Sci. U. S. A. 107:19002-19007.
28. Roy, K., S. Bartels, F. Qadri, and J. M. Fleckenstein. 2010. Enterotoxigenic Escherichia coli elicits immune responses to multiple surface proteins. Infect. Immun. 78:3027-3035.
29. Roy, K., D. Hamilton, K. P. Allen, M. P. Randolph, and J. M. Fleckenstein. 2008. The EtpA exoprotein of enterotoxigenic Escherichia coli promotes intestinal colonization and is a protective antigen in an experimental model of murine infection. Infect. Immun. 76:2106-2112. (Pubitemid 351656144)
30. Roy, K., D. Hamilton, M. M. Ostmann, and J. M. Fleckenstein. 2009. Vaccination with EtpA glycoprotein or flagellin protects against colonization with enterotoxigenic Escherichia coli in a murine model. Vaccine 27:4601-4608.
31. Roy, K., et al. 2009. Enterotoxigenic Escherichia coli EtpA mediates adhesion between flagella and host cells. Nature 457:594-598.
32. Schild, S., E. J. Nelson, and A. Camilli. 2008. Immunization with Vibrio cholerae outer membrane vesicles induces protective immunity in mice. Infect. Immun. 76:4554-4563.
33. Tsang, V. C., B. C. Wilson, and S. E. Maddison. 1980. Kinetic studies of a quantitative single-tube enzyme-linked immunosorbent assay. Clin. Chem. 26:1255-1260. (Pubitemid 10035222)
34. WHO. 2006. Future directions for research on enterotoxigenic Escherichia coli vaccines for developing countries. Wkly. Epidemiol. Rec. 81:97-104.